Chard DT - Search Results

1

Mind the gap: from neurons to networks to outcomes in multiple sclerosis.

Chard DT, Alahmadi AAS, Audoin B, Charalambous T, Enzinger C, Hulst HE, Rocca MA, Rovira À, Sastre-Garriga J, Schoonheim MM, Tijms B, Tur C, Gandini Wheeler-Kingshott CAM, Wink AM, Ciccarelli O, Barkhof F; MAGNIMS Study Group. Chard DT, et al. Nat Rev Neurol. 2021 Mar;17(3):173-184. doi: 10.1038/s41582-020-00439-8. Epub 2021 Jan 12. Nat Rev Neurol. 2021. PMID: 33437067 Review.

2

Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study.

Kapeller P, McLean MA, Griffin CM, Chard D, Parker GJ, Barker GJ, Thompson AJ, Miller DH. Kapeller P, et al. J Neurol. 2001 Feb;248(2):131-8. doi: 10.1007/s004150170248. J Neurol. 2001. PMID: 11284131

3

Diffusion tensor imaging in early relapsing-remitting multiple sclerosis.

Griffin CM, Chard DT, Ciccarelli O, Kapoor B, Barker GJ, Thompson AI, Miller DH. Griffin CM, et al. Among authors: chard dt. Mult Scler. 2001 Oct;7(5):290-7. doi: 10.1177/135245850100700504. Mult Scler. 2001. PMID: 11724444

4

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH. Chard DT, et al. Brain. 2002 Feb;125(Pt 2):327-37. doi: 10.1093/brain/awf025. Brain. 2002. PMID: 11844733

5

The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.

Griffin CM, Chard DT, Parker GJ, Barker GJ, Thompson AJ, Miller DH. Griffin CM, et al. Among authors: chard dt. J Neurol. 2002 Feb;249(2):193-9. doi: 10.1007/pl00007864. J Neurol. 2002. PMID: 11985386

6

Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS.

Traboulsee A, Dehmeshki J, Brex PA, Dalton CM, Chard D, Barker GJ, Plant GT, Miller DH. Traboulsee A, et al. Neurology. 2002 Jul 9;59(1):126-8. doi: 10.1212/wnl.59.1.126. Neurology. 2002. PMID: 12105321

7

Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis.

Kapeller P, Brex PA, Chard D, Dalton C, Griffin CM, McLean MA, Parker GJ, Thompson AJ, Miller DH. Kapeller P, et al. Mult Scler. 2002 May;8(3):207-10. doi: 10.1191/1352458502ms822oa. Mult Scler. 2002. PMID: 12120691

8

Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.

Chard DT, Griffin CM, McLean MA, Kapeller P, Kapoor R, Thompson AJ, Miller DH. Chard DT, et al. Brain. 2002 Oct;125(Pt 10):2342-52. doi: 10.1093/brain/awf240. Brain. 2002. PMID: 12244090

9

Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.

Leary SM, Miller DH, Stevenson VL, Brex PA, Chard DT, Thompson AJ. Leary SM, et al. Among authors: chard dt. Neurology. 2003 Jan 14;60(1):44-51. doi: 10.1212/wnl.60.1.44. Neurology. 2003. PMID: 12525716 Clinical Trial.

10

The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study.

Dehmeshki J, Chard DT, Leary SM, Watt HC, Silver NC, Tofts PS, Thompson AJ, Miller DH. Dehmeshki J, et al. Among authors: chard dt. J Neurol. 2003 Jan;250(1):67-74. doi: 10.1007/s00415-003-0955-x. J Neurol. 2003. PMID: 12527995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page